<!DOCTYPE html>

<html lang="fa">
<meta content="text/html;charset=utf-8" http-equiv="content-type"/>
<head><title>Collagen hemostat: Drug information</title><link href="/d/css/bootstrap.min.css" rel="stylesheet"/><link href="/d/css/icofont.min.css" rel="stylesheet"/><link href="/d/css/classy-nav.min.css" rel="stylesheet"/><link href="/d/css/animate.css" rel="stylesheet"/><link href="/d/css/owl.carousel.css" rel="stylesheet"/><link href="/d/css/magnific-popup.css" rel="stylesheet"/><link href="/d/css/owl.theme.default.min.css" rel="stylesheet"/><link href="/d/css/style.css" rel="stylesheet"/><link href="/d/css/rtl_edited.css" rel="stylesheet"/><link href="/d/css/responsive.css" rel="stylesheet"/><link href="https://medilib.ir/uptodate_assets/main.css" rel="stylesheet">
<style>

#myUL {
  list-style-type: none;
  padding: 0;
  margin: 0;
}

#myUL li a {
  border: 1px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #f6f6f6;
  padding: 12px;
  text-decoration: none;
  font-size: 16px;
  color: black;
  display: block
}

#myUL li a:hover:not(.header) {
  background-color: #eee;
}

#searchResult {

  list-style-type: none;
  padding: 0;
  padding-right: 20px;
}

#searchResult li a {
  border: .5px solid #ddd;
  margin-top: -1px; /* Prevent double borders */
  background-color: #79bc21;
  padding: 7px;
  text-decoration: none;
  font-size: 14px;
  color: white;
  display: block
}

#searchResult li a:hover:not(.header) {
  background-color: #222;
}


#txtHint   {
  position: absolute;
  text-shadow: none;
  width: 100%;
  margin-top: -15px;
  padding-right: 10px;

  filter: alpha(opacity=95);
  -moz-opacity: 0.95;
  opacity: 1;
  z-index: 200;
}
.countBubl {
  background:#eb0029;
  color:#fff;
  padding:5px;
  margin-top: 50%;

}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(2) {
 width: 55%;
 padding-left: 20px;
}
.uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > span:nth-child(1) > img:nth-child(3) {
 width: 20%;
}
 #Uptodate_image {
      width: 50%;
  }#uptodate-area {
      /*z-index: 99;*/
  }
#uptodate-area > div:nth-child(1) > div:nth-child(1) > div:nth-child(1) > div:nth-child(2) {
 margin-left: 10px;
 margin-bottom: 6%;
}
@media (max-width: @screen-xs) {
    .countBubl {
        font-size: 4px ;
    }
    #uptodate_version {
        font-size: 4px ;
    }
}

@media (max-width: @screen-sm) {
    .countBubl {
        font-size: 14px ;
    }
}
@media  all and(max-width: 820) {
    #Uptodate_image {
        width: 80% ;
    }#uptodate-area {
        z-index: 99;
    }
}@media  all and (min-width: 820) and(max-width: 88820){
    #Uptodate_image {
        width: 100% !important;
    }
    .countBubl {
        font-size: 4px ;
    }
}
div.col-md-3:nth-child(3) {
 margin-top: 6%;
}

div.col-md-3:nth-child(3) > img:nth-child(1) {
 width: 100%;
 margin-left: 11px;
}

</style>
<style media="screen" type="text/css">
  .goback {
    width: 200px;
    height: 40px;
    line-height: 40px;
    position: fixed;
    display: none;
    font-size: 15px;
    background: #71c0fa;
    z-index: 1000;
    text-align: center;
    color: #ffffff;
    -webkit-border-radius: 1px;
    -moz-border-radius: 1px;
    border-radius: 50px;
    bottom: 3.8%;
    right: 2%;
}
  .buyPackage {
  width: 100px;
  height: 100px;
  line-height: 40px;
  position: fixed;
  display: none;
  font-size: 10px;
  background: #fa759e;
  z-index: 1000;
  text-align: center;
  color: #ffffff;
  -webkit-border-radius: 1px;
  -moz-border-radius: 1px;
  border-radius: 10px;
  top: 150px;
  right: 2%;
  text-align: center;
}
.uptodate-area {
  /*background-image: url(../../assets/img/news-letter-bg.jpg);*/
  background-position: center center;
  background-size: cover;
  background-repeat: no-repeat;
    background-attachment: fixed;
  position: relative;
}
.uptodate-area::before {
  content: '';
  position: absolute;
  left: 0;
  padding-top: 100px;
  width: 100%;
}
#references{
  display: none;
}
</style>
<style>
section.sticky {
  position: sticky;
  top: 0;
  background-color: #fff !important;
  /*z-index: 100;*/
  /*padding-top: 80px;*/

}
.m4inb{
    border: solid !important;
  }

  .newsletter-area::before {
       background: unset !important;
  }
p {
    color: #555;
}
</style>

<meta content="" name="description"/>
<link href="/d/img/favicon.png" rel="icon" type="image/png"/>
</link></head>
<body>
<!-- Start Main Menu Area -->

<br/>
<br/>
<br/>
<br/>
<div class="container">
<div class="row">
</div>
</div>




<section class="teacher-area ptb-10">
<div class="container">
</div>

<section class="course-details-area ptb-60">
<div class="container">
<div class="uptodate2" style="padding:50px 0px 50px 0px;direction: ltr;text-align: left;">
<h1 style="text-align:center">Collagen hemostat: Drug information</h1>
<div class="utdArticleSection utdStyle" id="topicContent"><div id="drugTitle">Collagen hemostat: Drug information</div><div class="clear"></div><div id="topicText">For abbreviations, symbols, and age group definitions used in Lexicomp (<a class="graphic graphic_table" href="/d/html/57469.html" rel="external">show table</a>)<div class="visuallyHidden drugH1Div" id="formulinkBodyPlaceholder"><span class="drugH1"></span></div>
<div class="list ubnlist drugH1Div drugBrandNames" id="F196383"><span class="drugH1">Brand Names: US</span>
<ul>
<li>Actifoam Collagen Sponge;</li>
<li>Avitene;</li>
<li>Avitene Flour;</li>
<li>Endo Avitene;</li>
<li>Syringe Avitene;</li>
<li>Ultrafoam Sponge 2x6.25x7CM;</li>
<li>Ultrafoam Sponge 8x12.5x1CM;</li>
<li>Ultrafoam Sponge 8x12.5x3CM;</li>
<li>Ultrafoam Sponge 8x25x1CM;</li>
<li>Ultrafoam Sponge 8x6.25x1CM</li></ul></div>
<div class="ex_sect_xr thclist drugH1Div drugBrandNames" id="F196390"><span class="drugH1">Pharmacologic Category</span>
<ul>
<li>
                        Hemostatic Agent</li></ul></div>
<div class="block doa drugH1Div" id="F196384"><span class="drugH1">Dosing: Adult</span>
<div class="collapsible-indication">
<span class="collapsible-indication-title" data-indication-id="e590f407-a981-4bcb-87e2-a1fa67c2e693">Hemostasis</span>
<div class="collapsible-indication-wrap">
<p style="text-indent:-2em;margin-left:2em;">
<b>Hemostasis: Topical:</b> Apply dry directly to source of bleeding; remove excess material after ~5 to 10 minutes. If breakthrough bleeding occurs in areas of thin application, additional product may be applied depending on the severity of bleeding (in capillary bleeding, 1 g will usually be sufficient for a 50 cm<sup>2</sup> area; thicker coverage will be required for more brisk bleeding).</p></div>
</div>
</div>
<div class="block dora drugH1Div" id="F50990236"><span class="drugH1">Dosing: Kidney Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling.</p></div>
<div class="block doha drugH1Div" id="F50987557"><span class="drugH1">Dosing: Hepatic Impairment: Adult</span>
<p style="text-indent:0em;display:inline">There are no dosage adjustments provided in the manufacturer’s labeling.</p></div>
<div class="block doe drugH1Div" id="F196385"><span class="drugH1">Dosing: Older Adult</span>
<p style="text-indent:0em;display:inline">Refer to adult dosing.</p></div>
<div class="block adr drugH1Div" id="F196368"><span class="drugH1">Adverse Reactions</span>
<p style="text-indent:0em;display:inline">The following adverse drug reactions and incidences are derived from product labeling unless otherwise specified.</p>
<p style="text-indent:-2em;margin-left:2em;">Postmarketing:</p>
<p style="text-indent:-2em;margin-left:4em;">Hypersensitivity: Anaphylaxis (Woodruff 2014)</p>
<p style="text-indent:-2em;margin-left:4em;">Neuromuscular &amp; skeletal: Laryngospasm (transient; with dental use)</p>
<p style="text-indent:-2em;margin-left:4em;">Miscellaneous: Granuloma (including colonic serosa, foreign body granuloma) (Doita 2006, McGregor 1986), seroma (subgaleal)</p></div>
<div class="block coi drugH1Div" id="F196377"><span class="drugH1">Contraindications</span>
<p style="text-indent:0em;display:inline">Closure of skin incisions; application to bone surfaces to which prosthetic materials are attached with methylmethacrylate adhesives.</p></div>
<div class="block war drugH1Div" id="F196365"><span class="drugH1">Warnings/Precautions</span>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>
<i>Concerns related to adverse effects:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Pain/numbness/paralysis: Pain, numbness, or paralysis have been reported if used near a bony or neural space and left inside patient; use minimum amount necessary to achieve hemostasis (FDA, 2004).</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>
<i>Dosage forms specific issues:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Sponge: Do not use in instances of pumping arterial hemorrhage, where blood or other fluids have pooled, or where the point of hemorrhage is submerged as it may mask an underlying source of bleeding, resulting in hematoma.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">
<b>
<i>Other warnings/precautions:</i></b></p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Appropriate use: Not for injection, intraocular, or intravascular use. Do not use as a surface dressing except for immediate control of bleeding; use minimum amount necessary to achieve hemostasis. Avoid spillage on nonbleeding surfaces particularly in abdominal or thoracic viscera. Remove as much of agent as possible after hemostasis is achieved. Do not use in conjunction with autologous blood salvage circuits because fragments of MCH may pass through filters of blood scavenging systems; avoid reintroduction of blood from operative sites treated with MCH. Not intended to treat systemic coagulation disorders. Do not reuse, reprocess, resterilize, or repackage because doing so may lead to device failure or create a risk of contamination of the device and/or cause patient infection or cross infection.</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Bovine origin: Contains bovine serum protein; increases in anti-BSA titer have been observed. Use is not recommended in patients sensitive to bovine derived collagen.</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">• Infection: Use in contaminated wounds may enhance infection; do not leave MCH in a contaminated or infected space.</p></div>
<div class="block foc drugH1Div" id="F196373"><span class="drugH1">Dosage Forms: US</span>
<p style="text-indent:0em;text-align:justify;display:inline">Excipient information presented when available (limited, particularly for generics); consult specific product labeling.</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Miscellaneous, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Actifoam Collagen Sponge:  (10 ea)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Endo Avitene:  (1 ea)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Syringe Avitene:  (1 g)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Ultrafoam Sponge 2x6.25x7CM: 2 cm x 6.25 cm x 7 cm (1 ea)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Ultrafoam Sponge 8x12.5x1CM: 8 cm x 12.5 cm x 1 cm (1 ea)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Ultrafoam Sponge 8x12.5x3CM: 8 cm x 12.5 cm x 3 cm (1 ea)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Ultrafoam Sponge 8x25x1CM: 8 cm x 25 cm x 1 cm (1 ea)</p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Ultrafoam Sponge 8x6.25x1CM: 8 cm x 6.25 cm x 1 cm (1 ea)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Pad, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Avitene:  (1 ea)</p>
<p style="text-indent:-2em;margin-left:2em;text-align:justify;">Powder, External: </p>
<p style="text-indent:-2em;margin-left:4em;text-align:justify;">Avitene Flour:  (6 ea, 1 g, 5 g)</p></div>
<div class="block geq drugH1Div" id="F196361"><span class="drugH1">Generic Equivalent Available: US</span>
<p style="text-indent:0em;display:inline">No</p></div>
<div class="block adm drugH1Div" id="F45748858"><span class="drugH1">Administration: Adult</span>
<p style="text-indent:0em;display:inline">For topical use only in in surgical procedures; not for injection, intraocular, or intravascular use. MCH will adhere to wet gloves, instruments, or tissue surfaces; use dry, smooth forceps or a pre-loaded applicator device to apply. Surfaces to be treated should be compressed with dry sponges immediately prior to application. Administer dry (avoiding spillage on nonbleeding surfaces) and then apply pressure over the application site with a dry sponge until hemostasis results (1 minute may suffice for capillary bleeding, but &gt;3 to 5 minutes may be required for brisk bleeding or high pressure leaks in major artery suture holes). For control of oozing from cancellous bone, firmly pack into the spongy bone surface. Avoid packing tightly in cavities, especially within the bony enclosure of the CNS or within other relatively rigid cavities where swelling may interfere with normal function or possibly cause necrosis. After ~5 to10 minutes, remove excess material with blunt forceps and facilitate by wetting with sterile NS and irrigation.</p></div>
<div class="block use drugH1Div" id="F196374"><span class="drugH1">Use: Labeled Indications</span>
<p style="text-indent:0em;display:inline">
<b>Hemostasis:</b> Adjunct to hemostasis in surgical procedures when control of bleeding by ligature or conventional procedures is ineffective or impractical.</p></div>
<div class="block mst drugH1Div" id="F196395"><span class="drugH1">Medication Safety Issues</span>
<div class="collapsible">
<span class="collapsible-title">Sound-alike/look-alike issues: </span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">Avitene may be confused with Ativan</p></div>
</div>
<div class="collapsible">
<span class="collapsible-title">Other safety concerns:</span>
<div class="collapsible-wrap">
<p style="text-indent:-2em;margin-left:4em;">Over 100 reports of paralysis or other neural deficits have been received by the FDA, attributable to collagen hemostat-associated neuronal impingement; see Warnings/Precautions</p></div>
</div>
</div>
<div class="block cyt drugH1Div" id="F13299089"><span class="drugH1">Metabolism/Transport Effects</span>
<p style="text-indent:0em;display:inline">None known.</p></div>
<div class="block dri drugH1Div" id="F196369"><span class="drugH1">Drug Interactions</span>
<br/><br/><div class="clear"></div><p style="text-indent:0em;display:inline">There are no known significant interactions.</p></div>
<div class="block pha drugH1Div" id="F196364"><span class="drugH1">Mechanism of Action</span>
<p style="text-indent:0em;display:inline">Collagen hemostat is an absorbable topical hemostatic agent prepared from purified bovine corium collagen and shredded into fibrils. Physically, microfibrillar collagen hemostat yields a large surface area. Chemically, it is collagen with hydrochloric acid noncovalently bound to some of the available amino groups in the collagen molecules. When in contact with a bleeding surface, collagen hemostat attracts platelets which adhere to its fibrils and undergo the release phenomenon. This triggers aggregation of the platelets into thrombi in the interstices of the fibrous mass, initiating the formation of a physiologic platelet plug.</p></div>
<div class="block phk drugH1Div" id="F196376"><span class="drugH1">Pharmacokinetics (Adult Data Unless Noted)</span>
<p style="text-indent:0em;text-align:justify;display:inline">Onset of hemostasis: 2 to 5 minutes</p></div>
</div><div class="headingAnchor" id="references"><ol id="reference">
<li>
<div class="reference">
                  Avitene (microfibrillar collagen hemostat) [prescribing information]. Warwick, RI: Davol; 2011.</div>
</li>
<li>
<div class="reference">
                  Avitene Ultrafoam (microfibrillar collagen hemostat) [prescribing information]. Warwick, RI: Davol; Received September 2015.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-16541256">
<a name="16541256"></a>Doita M, Nishida K, Kurosaka M. Radiculopathy due to microfibrillar collagen hemostat mimicking recurrence of disc herniation. <i>Skeletal Radiol</i>. 2006;35(12):953-955. doi:10.1007/s00256-006-0090-8<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/collagen-hemostat-drug-information/abstract-text/16541256/pubmed" id="16541256" target="_blank">16541256</a>]</span>
</div>
</li>
<li>
<div class="reference">
                  FDA Public Health Notification: Paralysis from Absorbable Hemostatic Agent. 2004. Available at <a href="http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/PublicHealthNotifications/ucm062146.htm" target="_blank">http://www.fda.gov/MedicalDevices/Safety/AlertsandNotices/PublicHealthNotifications/ucm062146.htm</a>.</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-3740798">
<a name="3740798"></a>McGregor DH, MacArthur RI, Carter T. Avitene granulomas of colonic serosa. <i>Ann Clin Lab Sci</i>. 1986;16(4):296-302.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/collagen-hemostat-drug-information/abstract-text/3740798/pubmed" id="3740798" target="_blank">3740798</a>]</span>
</div>
</li>
<li>
<div class="reference" id="lexi-content-ref-25842652">
<a name="25842652"></a>Woodruff S, Early R, Qoos W. Anaphylactic reaction with avitene: a pediatric case report. <i>AANA J</i>. 2014;82(5):368-374.<span class="pubmed-id"> [PubMed <a href="https://www.uptodate.com/contents/collagen-hemostat-drug-information/abstract-text/25842652/pubmed" id="25842652" target="_blank">25842652</a>]</span>
</div>
</li></ol></div><div id="topicVersionRevision">Topic 8507 Version 68.0</div></div>
</div>
</div>

</section>

</section>
<!-- End Main Menu Area -->
<!-- Start Search Popup Area -->


<!-- End Footer Area -->
<!-- Back to top -->

<a class="scrolltop" href="#top"><i class="icofont-hand-drawn-up"></i></a>
<!-- End Back to top -->
<!-- jQuery Min JS -->

<!-- Prpper JS -->

<!-- Bootstrap Min JS -->

<!-- Classy Nav Min Js -->

<!-- Owl Carousel Min Js -->

<!-- Magnific Popup JS -->

<!-- CounterUp JS -->

<!-- Waypoints JS -->

<!-- Form Validator Min JS -->

<!-- Contact Form Min JS -->

<!-- Main JS -->

<!-- Global site tag (gtag.js) - Google Analytics -->






</body>
</html>
